OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serum integrative omics reveals the landscape of human diabetic kidney disease
Shijia Liu, Yuan Gui, Mark S. Wang, et al.
Molecular Metabolism (2021) Vol. 54, pp. 101367-101367
Open Access | Times Cited: 48
Shijia Liu, Yuan Gui, Mark S. Wang, et al.
Molecular Metabolism (2021) Vol. 54, pp. 101367-101367
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 361
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 361
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease
Pedro Pereira, David F. Carrageta, Pedro F. Oliveira, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1518-1544
Closed Access | Times Cited: 89
Pedro Pereira, David F. Carrageta, Pedro F. Oliveira, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1518-1544
Closed Access | Times Cited: 89
Survey on Multi-omics, and Multi-omics Data Analysis, Integration and Application
Mohamad Hesam Shahrajabian, Wenli Sun
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 4, pp. 267-281
Closed Access | Times Cited: 53
Mohamad Hesam Shahrajabian, Wenli Sun
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 4, pp. 267-281
Closed Access | Times Cited: 53
Artificial intelligence in metabolomics: a current review
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 17
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 17
Diabetes in China: epidemiology, pathophysiology and multi-omics
Weiping Jia, Juliana C.N. Chan, Tien Yin Wong, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 2
Weiping Jia, Juliana C.N. Chan, Tien Yin Wong, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 2
Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts
Yuan Gui, Zachary Palanza, Haiyan Fu, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 24
Yuan Gui, Zachary Palanza, Haiyan Fu, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 24
Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 54-54
Open Access | Times Cited: 9
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 54-54
Open Access | Times Cited: 9
Multi-omics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
DengFeng Li, Fang‐Chi Hsu, Nicholette D. Palmer, et al.
Diabetes (2024) Vol. 73, Iss. 7, pp. 1188-1195
Open Access | Times Cited: 9
DengFeng Li, Fang‐Chi Hsu, Nicholette D. Palmer, et al.
Diabetes (2024) Vol. 73, Iss. 7, pp. 1188-1195
Open Access | Times Cited: 9
Identification of the Pharmacological Components and Its Targets of Sanghuang by Integration of Nontarget Metabolomics and Network Pharmacology Analysis
Hengqian Lu, Jingtao Zhang, Yongzhong Wang
Biomedical Chromatography (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
Hengqian Lu, Jingtao Zhang, Yongzhong Wang
Biomedical Chromatography (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease
Marta B. Lopes, Roberta Coletti, Flore Duranton, et al.
PROTEOMICS (2025)
Open Access | Times Cited: 1
Marta B. Lopes, Roberta Coletti, Flore Duranton, et al.
PROTEOMICS (2025)
Open Access | Times Cited: 1
The characterization of serum proteomics and metabolomics across the cancer trajectory in chronic hepatitis B‐related liver diseases
Jinsheng Xiao, Hang Liu, Jun Yao, et al.
View (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 6
Jinsheng Xiao, Hang Liu, Jun Yao, et al.
View (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 6
Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 5
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 5
Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease
I‐Wen Wu, Tsung-Hsien Tsai, Chi-Jen Lo, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 22
I‐Wen Wu, Tsung-Hsien Tsai, Chi-Jen Lo, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 22
Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease
Xinrong Jiang, Xingyue Liu, Xuetong Qu, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3188-3203
Open Access | Times Cited: 12
Xinrong Jiang, Xingyue Liu, Xuetong Qu, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3188-3203
Open Access | Times Cited: 12
Integrated metabolomics and mass spectrometry imaging analysis reveal the efficacy and mechanism of Huangkui capsule on type 2 diabetic nephropathy
Jinwei Han, Ping Li, Hui Sun, et al.
Phytomedicine (2025) Vol. 138, pp. 156397-156397
Closed Access
Jinwei Han, Ping Li, Hui Sun, et al.
Phytomedicine (2025) Vol. 138, pp. 156397-156397
Closed Access
Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study
Bianca Uliana Picolo, Nathália Rabello Silva, Mário Machado Martins, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Bianca Uliana Picolo, Nathália Rabello Silva, Mário Machado Martins, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Risk factors for postoperative acute kidney injury after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta-analysis and systematic review
Dengzhuo Chen, Yongli Ma, Jinghui Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Dengzhuo Chen, Yongli Ma, Jinghui Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Fermentation-enriched quinoa β-glucan ameliorates disturbed gut microbiota and metabolism in type 2 diabetes mellitus mice
Nan Ma, Rong Li, Guifang Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141666-141666
Closed Access
Nan Ma, Rong Li, Guifang Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141666-141666
Closed Access
Trigonella foenum-graecum L. protects against renal function decline in a mouse model of type 2 diabetic nephropathy by modulating the PI3K-Akt-ERK signaling pathway
Yang Niu, Hongjuan Niu, Liqun Chi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yang Niu, Hongjuan Niu, Liqun Chi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Association between serum α-klotho levels and the incidence of diabetic kidney disease and mortality in type 2 diabetes: evidence from a Chinese cohort and the NHANES database
Yi Kang, Jin Qian, Mengqi Zhou, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Yi Kang, Jin Qian, Mengqi Zhou, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics
Lan Wei, Yuanyuan Han, Chao Tu
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 117-128
Open Access | Times Cited: 9
Lan Wei, Yuanyuan Han, Chao Tu
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 117-128
Open Access | Times Cited: 9
Untargeted and spatial-resolved metabolomics characterize serum and tissue-specific metabolic reprogramming in acute kidney injury
Bei Xu, Wanyi Li, Yamei Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21171-e21171
Open Access | Times Cited: 8
Bei Xu, Wanyi Li, Yamei Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21171-e21171
Open Access | Times Cited: 8
Guild-level signature of gut microbiome for diabetic kidney disease
Shasha Tang, Guojun Wu, Yalei Liu, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 2
Shasha Tang, Guojun Wu, Yalei Liu, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 2
Serum and urine metabolomic biomarkers for predicting prognosis in patients with immunoglobulin A nephropathy
You Hyun Jeon, Sujin Lee, Da Woon Kim, et al.
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 5, pp. 591-605
Open Access | Times Cited: 6
You Hyun Jeon, Sujin Lee, Da Woon Kim, et al.
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 5, pp. 591-605
Open Access | Times Cited: 6
Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease
Claire Hill, Ione Ávila-Palència, Alexander P. Maxwell, et al.
Frontiers in Nephrology (2022) Vol. 2
Open Access | Times Cited: 8
Claire Hill, Ione Ávila-Palència, Alexander P. Maxwell, et al.
Frontiers in Nephrology (2022) Vol. 2
Open Access | Times Cited: 8
